Jpmorgan Chase & CO Nephros Inc Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Nephros Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 15 shares of NEPH stock, worth $22. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 221
93.21%
Holding current value
$22
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding NEPH
# of Institutions
18Shares Held
4.27MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$5.4 Million1.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA202KShares$302,9910.0% of portfolio
-
Bard Associates Inc Chicago, IL155KShares$232,9060.09% of portfolio
-
Geode Capital Management, LLC Boston, MA84.9KShares$127,2750.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL55.7KShares$83,5650.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $15.5M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...